Naveen K Mittal, M.D.

• Professional Background

  Education

  • 1996 - Postdoctoral Fellowship - Pediatric Gastroenterology - The University of Chicago Hospital
  • 1993 - Residency - Pediatrics - Hahnemann University Hospital
  • 1991 - Clinical Fellowship - Clinical Fellowship in Pedi-Gastroenterology - Bristol Royal Hospital
  • 1990 - Residency - Pediatrics - South Cleveland Hospital, Department of Pediatrics
  • 1988 - MD - Pediatrics - University of Delhi, Maulana Azad Medical College and Associated Hospitals
  • 1988 - Residency - Pediatrics - Maulana Azad Medical College and Associated Hospitals
  • 1985 - Residency - Surgery - Safdarjung Hospital, Department of Surgery
  • 1985 - Residency - Pediatrics - Safdarjung Hospital, Department of Pediatrics
  • 1984 - Internship - Pediatrics; Other Medical & Surgical Specialties - University College of Medical Sciences, Safdarjung Hospital
  • 1983 - BM BS - Medicine - University of Delhi, University College of Medical Sciences

  Appointments

  • 9/2014 - Greehey Family Foundation Endowed Chair in Pediatric Gastroenterology - University of Texas Health Science Center at San AntonioSan Antonio
  • 8/2014 - Medical Director - University Health System - Liver Transplant ProgramSan Antonio
  • 11/2013 - Chief, Division of Pediatric Gastroenterology, Hepatology & Nutrition - University Health SystemSan Antonio
  • 9/2009 - Professor/Clinical - University of Texas Health Science Center at San Antonio, Pediatrics, San Antonio
  • 6/2009 - Chief, Division of Pediatric Gastroenterology - University of Texas Health Science Center at San Antonio, Pediatrics, San Antonio

• Research & Grants

  Research profile

  Grants

  Private

  Funding Agency Gilead Sciences, Inc. Title Chronic Hepatitis B - A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects with Chronic Hepatitis B Virus Infection Status Active Period 1/2016 - Present Role Co-Principal Investigator Grant Detail Funding Agency Gilead Sciences, Inc. Title Hepatitis C Virus Infection - A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials Status Active Period 1/2016 - Present Role Co-Principal Investigator Grant Detail Funding Agency Gilead Sciences, Inc. Title Hepatitis C Virus Infection - A Phase 2, Open-Label, Multicenter, Multi-cohort, Single-Arm Study to Investigate the Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children with Genotype 2 or 3 Chronic HCV Infection Status Complete Period 1/2014 - 1/2018 Role Co-Principal Investigator Grant Detail

• Publications

  Abstract

  Antonishek JD, Shiu V, Blanco CL, Mittal N. Genetic Mutation of Microvillus Inclusion Disease-Like Phenotype; 2017 Feb. (Journal of Investigative Medicine). Keller L, Mittal N, Blanco CL. Markers of Liver Disease Remain Elevated in Infants With Severe PNALD While on IV FISH Therapy With and Without Soy-Based Intralipid; 2016 May. (Pediatric Research). Sitabkhan A, Moreira AG, Mittal N, Jacob R, Tragus R, Blanco CL. Severe Allergic Colitis Can Present With Elemental Formula Feeds in Infants with Severe Intestinal Failure: A Case Series; 2016 Feb. (Journal of Investigative Medicine). Jacob, Bonagurio, Moreira, Green, Tragus, Keller, Sorrell, Sitabkhan, Mittal N, Blanco CL. Favorable Outcomes of Preterm Infants Treated with Fish Oil-Based Intravenous Lipid Emulsion for Parenteral Nutrition-Associated Liver Disease; 2014 May. (E-PAS).

  Not Specified

  Keller LM, Kerecman J, Goodman Z, Mittal N, Blanco CL. Markers of Hepatic Injury Correlate with Histological Changes of Neonatal Parenteral Nutrition Associated Liver Disease Journal of Investigative Medicine 2016 Feb;.